Discovery Life Sciences: Albert Li

Albert Li will join Discovery Life Sciences as CSO of pharmacology and toxicology as part of the firm's recent acquisition of In Vitro ADMET Laboratories (IVAL). Li, who founded IVAL in 2004, has been pioneering the isolation, cryopreservation, and culturing of human hepatocytes and their use in evaluating drug metabolism, drug-drug interactions, and drug toxicity.